rxstat › Shortages › Triamcinolone Acetonide Gramicidin Nystatin Neomycin

Triamcinolone Acetonide Gramicidin Nystatin Neomycin shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Triamcinolone Acetonide Gramicidin Nystatin Neomycin products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 3
Reports on file
66

Reports by product

Discontinued
VIADERM KC CRM
1MG 0.25MG 100000UNIT 2.5MG · CREAM · TARO PHARMACEUTICALS INC
DIN 00717002
Resolved
VIADERM KC ONT
100000UNIT 1MG 0.25MG 2.5MG · OINTMENT · TARO PHARMACEUTICALS INC
DIN 00717029 · ended Feb 11, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-TRIACOMB
0.25MG 2.5MG 1MG 100000UNIT · CREAM · TEVA CANADA LIMITED
DIN 00550507 · ended Dec 17, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-TRIACOMB
0.25MG 2.5MG 1MG 100000UNIT · CREAM · TEVA CANADA LIMITED
DIN 00550507 · ended Dec 17, 2025 · Disruption of the manufacture of the drug.
Resolved
VIADERM KC CRM
0.25MG 100000UNIT 1MG 2.5MG · CREAM · TARO PHARMACEUTICALS INC
DIN 00717002 · ended Nov 10, 2025 · Disruption of the manufacture of the drug.
Resolved
VIADERM KC CRM
0.25MG 100000UNIT 1MG 2.5MG · CREAM · TARO PHARMACEUTICALS INC
DIN 00717002 · ended Oct 14, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-TRIACOMB
0.25MG 2.5MG 100000UNIT 1MG · CREAM · TEVA CANADA LIMITED
DIN 00550507 · ended Jun 12, 2025 · Disruption of the manufacture of the drug.
Discontinued
TEVA-TRIACOMB
0.25MG 2.5MG 1MG 100000UNIT · CREAM · TEVA CANADA LIMITED
DIN 00550507
Resolved
VIADERM KC CRM
100000UNIT 0.25MG 2.5MG 1MG · CREAM · TARO PHARMACEUTICALS INC
DIN 00717002 · ended Feb 20, 2025 · Disruption of the manufacture of the drug.
Resolved
VIADERM KC CRM
100000UNIT 0.25MG 2.5MG 1MG · CREAM · TARO PHARMACEUTICALS INC
DIN 00717002 · ended Feb 20, 2025 · Disruption of the manufacture of the drug.
Resolved
VIADERM KC CRM
100000UNIT 0.25MG 2.5MG 1MG · CREAM · TARO PHARMACEUTICALS INC
DIN 00717002 · ended Feb 7, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-TRIACOMB
0.25MG 2.5MG 100000UNIT 1MG · CREAM · TEVA CANADA LIMITED
DIN 00550507 · ended Jan 7, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

One or more Triamcinolone Acetonide Gramicidin Nystatin Neomycin products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Triamcinolone Acetonide Gramicidin Nystatin Neomycin is classified under “CORTICOSTEROIDS, COMB WITH ANTIBIOTICS” (ATC D07CB).

Recent changes

Common questions

When will Triamcinolone Acetonide Gramicidin Nystatin Neomycin be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Triamcinolone Acetonide Gramicidin Nystatin Neomycin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.